Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shock wave therapy shows promise for erectile dysfunction in new trial

NCT ID NCT03596047

Symptom relief Sponsor: Boston Medical Group Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding radial shock wave therapy to standard sildenafil (Viagra) helps men with erectile dysfunction more than sildenafil alone. Eighty men with moderate ED were randomly assigned to receive either real shock waves or a fake treatment, plus sildenafil. The main goal was to see if the combination improved erectile function scores after six weeks of treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Apr 2018

Finished

Mar 2021

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men older than 18 years * Erectile dysfunction present more for more than 3 months in more than 50% of intercourse. * IIEF-EF score between 11 and 21. * Patient who agrees to enter the study through the signing of an informed consent. Exclusion Criteria: * EHS score of 4 * Bladder, prostate or colon cancer. * ED of psychological origin. * Patients with spinal cord injury. * Patients with anticoagulant use. * Patients with sickle cell anemia. * Patients with clinical suspicion of hypogonadism (AMS greater than 36, Annex 1). * Patients with infections or active lesions of the penis or pubic area. * Patients with ED secondary to drug treatment (antiandrogenic therapy, antidepressants, use of corticosteroids, antiparkinsonians, antipsychotics). * Radical prostatectomy or other radical pelvic surgery. * Antecedents of pelvic radiotherapy. * Patients with penile implant. * Endocrine diseases that occur with ED: acromegaly, gigantism, Addison's disease, hyperprolactinemia, androgenic deficiency. * Patients with neurological diseases (Parkinson's, CVD, dementia of any origin)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Erectile dysfunction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

erectile dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Erectile dysfunction

Contacts and locations

Locations

  • Boston Medical Group Colombia

    Bogotá, Cundinamarca, 11022, Colombia

More trials for these conditions

Other studies related to the condition(s) this trial covers.